IS-02 - Updates in Regenerative Medicine

Thursday, November 21, 2024

10:00 AM - 12:00 PM PT

Location: Julius 21-23

CE: 2

Lead(s)

Dmitri Souza, MD

Professor of Surgery, Professor of Medicine
Northeast Ohio Medical University

Disclosure(s):

Dmitri Souza, MD: AbbVie: Speakers Bureau (Ongoing); Scilex Pharmaceuticals: Consulting/Advisory Board (Terminated, January 1, 2022); Springer: Royalties/Patent (Ongoing)

Learning Objectives:

Review the reasons behind the existing evidence gap between "orthobiologics" and spine pain procedures in regenerative medicine and discuss strategies to bridge this gap
Identify the latest regulatory updates in regenerative medicine and explain their implications for clinical practice and patient safety
Develop strategies for effectively organizing a regenerative medicine practice, including understanding billing and coding processes, and implementing cost reduction strategies
Critically assess the current understanding of the mechanism of action in regenerative medicine, and consider whether a new title or conceptual framework is needed for the field

Presentations:

10:00 AM - 10:15 AM PT

Why Do We Have an Evidence Gap Between “Orthobiologics” and Spine Pain Procedures in Regenerative Medicine?
Speaker: Yashar Eshraghi, MD – Ochsner Health System
10:15 AM - 10:30 AM PT

Regulatory Updates
Speaker: Jianguo Cheng, MD, PhD (he/him/his) – Cleveland Clinic
10:30 AM - 10:45 AM PT

Organizing a Regenerative Medicine Practice - Including B&C, Cost Reduction Strategies
Speaker: Yashar Eshraghi, MD – Ochsner Health System
10:45 AM - 11:00 AM PT

“Regenerative Medicine” and Mechanism of Action: Time for a New Title?
Speaker: Thomas Buchheit, MD – Duke University
11:00 AM - 12:00 PM PT

Panel Discussion and Open Forum